Strunnikova N - Search Results

1

Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression.

Strunnikova N, Ray SC, Livingston RA, Rubalcaba E, Viscidi RP. Strunnikova N, et al. J Virol. 1995 Dec;69(12):7548-58. doi: 10.1128/JVI.69.12.7548-7558.1995. J Virol. 1995. PMID: 7494261 Free PMC article.

2

Evolution of human immunodeficiency virus type 1 in relation to disease progression in children.

Strunnikova N, Ray SC, Lancioni C, Nguyen M, Viscidi RP. Strunnikova N, et al. J Hum Virol. 1998 Mar-Apr;1(3):224-39. J Hum Virol. 1998. PMID: 10195246

3

Regulated heat shock protein 27 expression in human retinal pigment epithelium.

Strunnikova N, Baffi J, Gonzalez A, Silk W, Cousins SW, Csaky KG. Strunnikova N, et al. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2130-8. Invest Ophthalmol Vis Sci. 2001. PMID: 11481282

4

Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis.

Strunnikova N, Zhang C, Teichberg D, Cousins SW, Baffi J, Becker KG, Csaky KG. Strunnikova N, et al. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3767-77. doi: 10.1167/iovs.04-0311. Invest Ophthalmol Vis Sci. 2004. PMID: 15452088

5

Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury.

Strunnikova N, Hilmer S, Flippin J, Robinson M, Hoffman E, Csaky KG. Strunnikova N, et al. Free Radic Biol Med. 2005 Sep 15;39(6):781-96. doi: 10.1016/j.freeradbiomed.2005.04.029. Free Radic Biol Med. 2005. PMID: 16109308

6

Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors.

An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman EP, Strunnikova N, Csaky K, Hathout Y. An E, et al. Among authors: strunnikova n. J Proteome Res. 2006 Oct;5(10):2599-610. doi: 10.1021/pr060121j. J Proteome Res. 2006. PMID: 17022631

7

NINDS launches network to develop treatments for ultra-rare neurological diseases.

Schor NF, Tamiz AP, Koroshetz WJ; NINDS Ultra-Rare Gene-based Therapy (URGenT) Working Group; Broome AM. Schor NF, et al. Nat Biotechnol. 2021 Dec;39(12):1497-1499. doi: 10.1038/s41587-021-01125-w. Nat Biotechnol. 2021. PMID: 34737446 No abstract available.

8

Multiple A2E treatments lead to melanization of rod outer segment-challenged ARPE-19 cells.

Poliakov E, Strunnikova NV, Jiang JK, Martinez B, Parikh T, Lakkaraju A, Thomas C, Brooks BP, Redmond TM. Poliakov E, et al. Among authors: strunnikova nv. Mol Vis. 2014 Mar 14;20:285-300. eCollection 2014. Mol Vis. 2014. PMID: 24644403 Free PMC article.

9

Serum biomarkers and trafficking defects in peripheral tissues reflect the severity of retinopathy in three brothers affected by choroideremia.

Strunnikova N, Zein WM, Silvin C, MacDonald IM. Strunnikova N, et al. Adv Exp Med Biol. 2012;723:381-7. doi: 10.1007/978-1-4614-0631-0_49. Adv Exp Med Biol. 2012. PMID: 22183356 No abstract available.

10

SU5416 induces premature senescence in endothelial progenitor cells from patients with age-related macular degeneration.

Thill M, Berna MJ, Kunst F, Wege H, Strunnikova NV, Gordiyenko N, Grierson R, Richard G, Csaky KG. Thill M, et al. Among authors: strunnikova nv. Mol Vis. 2011 Jan 10;17:85-98. Mol Vis. 2011. PMID: 21245959 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters